Haptoglobin glycoforms in a case of carbohydrate-deficient glycoprotein syndrome

M Ferens-Sieczkowska, A Midro… - Glycoconjugate …, 1999 - Springer
M Ferens-Sieczkowska, A Midro, B Mierzejewska-Iwanowska, K Zwierz, I Kątnik-Prastowska
Glycoconjugate Journal, 1999Springer
Alterations in haptoglobin (Hp) glycosylation were examined in the plasma of the first patient
with carbohydrate-deficient glycoprotein syndrome (CDGS) who was described in Poland.
Hp concentration in the CDGS patient plasma was low (240mg/l) and the Hp phenotype was
shown to be 2-2. Three glycoforms of the Hp β subunit were observed in SDS-PAGE in
CDGS. The densitometric analysis and molecular weight determinations suggested that
50% of glycoforms were fully glycosylated; 30% contained three out of four and 20% only …
Abstract
Alterations in haptoglobin (Hp) glycosylation were examined in the plasma of the first patient with carbohydrate-deficient glycoprotein syndrome (CDGS) who was described in Poland. Hp concentration in the CDGS patient plasma was low (240mg/l) and the Hp phenotype was shown to be 2-2. Three glycoforms of the Hp β subunit were observed in SDS-PAGE in CDGS. The densitometric analysis and molecular weight determinations suggested that 50% of glycoforms were fully glycosylated; 30% contained three out of four and 20% only two out of four glycan units compared to those that are present in Hp derived from healthy people. Results with lectins (concanavalin A and Sambucus nigra, Maackia amurensis and Alleuria aurantia agglutinins) indicate that all three glycoforms of β subunit of CDGS-Hp contained biantennary complex glycans terminated with α2,6 bound sialic acid, but without fucose or α2,3 linked sialic acid. Hp glycosylation abnormalities described in this work suggest that this case was a type I carbohydrate-deficient glycoprotein syndrome.
Springer